SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/30/21 Artemis Therapeutics, Inc. 10-K 12/31/20 42:2M Z-K Global Ltd./FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 317K 2: EX-31.1 Certification -- §302 - SOA'02 -- exhibit_31-1 HTML 17K 3: EX-32.1 Certification -- §906 - SOA'02 -- exhibit_32-1 HTML 14K 10: R1 Document and Entity Information HTML 51K 11: R2 Consolidated Balance Sheet HTML 72K 12: R3 Consolidated Balance Sheet (Parenthetical) HTML 33K 13: R4 Consolidated Statement of Operation HTML 42K 14: R5 Consolidated Statements of changes of HTML 35K shareholder's equity (Deficiency) 15: R6 Consolidated Statement of Cash Flows HTML 45K 16: R7 General HTML 22K 17: R8 Significant Accounting Policies HTML 27K 18: R9 Commitments and Contingencies HTML 17K 19: R10 Income Tax HTML 42K 20: R11 Warrants Issued to Investors HTML 19K 21: R12 Computation of Net Loss per Share HTML 29K 22: R13 Stock Capital HTML 57K 23: R14 Related Parties HTML 17K 24: R15 Subsequent Events HTML 16K 25: R16 Significant Accounting Policies (Policies) HTML 49K 26: R17 Income Tax (Tables) HTML 38K 27: R18 Warrants Issued to Investors (Tables) HTML 20K 28: R19 Computation of Net Loss per Share (Tables) HTML 28K 29: R20 Stock Capital (Tables) HTML 53K 30: R21 Commitments and Contingencies (Details) HTML 18K 31: R22 Income Tax (Narrative) (Details) HTML 21K 32: R23 Income Tax (Schedule of Deferred Income Taxes) HTML 19K (Details) 33: R24 Income Tax (Schedule of Net Operating Loss HTML 18K Carryforwards) (Details) 34: R25 Warrants Issued to Investors (Details) HTML 19K 35: R26 Computation of Net Loss per Share (Schedule of HTML 35K Calculation of Basic Loss Per Share) (Details) 36: R27 Stock Capital (Narrative) (Details) HTML 42K 37: R28 Stock Capital (Summary of Stock Option Activity) HTML 41K (Details) 38: R29 Stock Capital (Summary of Stock Option Exercise HTML 30K price) (Details) 39: R30 Related Parties (Narrative) (Details) HTML 23K 41: XML IDEA XML File -- Filing Summary XML 71K 40: EXCEL IDEA Workbook of Financial Reports XLSX 40K 4: EX-101.INS XBRL Instance -- atms-20201231 XML 488K 6: EX-101.CAL XBRL Calculations -- atms-20201231_cal XML 70K 7: EX-101.DEF XBRL Definitions -- atms-20201231_def XML 211K 8: EX-101.LAB XBRL Labels -- atms-20201231_lab XML 433K 9: EX-101.PRE XBRL Presentations -- atms-20201231_pre XML 325K 5: EX-101.SCH XBRL Schema -- atms-20201231 XSD 82K 42: ZIP XBRL Zipped Folder -- 0001178913-21-001229-xbrl Zip 57K
Download this zipped .zip folder | |
Files: | atms-20201231.xml atms-20201231.xsd atms-20201231_cal.xml atms-20201231_def.xml atms-20201231_lab.xml atms-20201231_pre.xml |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/19/19 Manuka, Inc. 10-Q 6/30/19 43:2.4M Z-K Global Ltd./FA 10/25/17 Manuka, Inc. 8-K:1,3,5,910/25/17 4:558K Z-K Global Ltd./FA 8/29/16 Manuka, Inc. 8-K:1,2,3,5 8/29/16 5:1M Z-K Global Ltd./FA 8/09/11 Artemis Therapeutics, Inc. DEF 14A 8/09/11 1:626K Z-K Global Ltd./FA 9/24/10 Artemis Therapeutics, Inc. 8-K:5,9 9/24/10 5:52K Z-K Global Ltd./FA 4/04/08 Artemis Therapeutics, Inc. 8-K:5,9 4/04/08 2:5K Z-K Global Ltd./FA 11/14/02 Artemis Therapeutics, Inc. 10QSB 9/30/02 6:113K Bowne & C… Smartedgar/FA |